ARTICLE | Top Story
Celera buys asthma compounds
October 8, 2002 7:00 AM UTC
CRA purchased all rights and compounds under a 1994 asthma deal between Bayer (BAY; FSE:BAYG) and Axys, which CRA acquired last year. CRA also will receive study data and relevant IP relating to oral ...